Regenxbio RGNX
NASDAQ RGNX
$7.43 +0.01 (+0.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regenxbio (RGNX) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Regenxbio (RGNX) posted Return on Capital Employed [ROCE] of -42.72% for Q2 2026, down 3.20 percentage points from -39.52% a year earlier.

Analysis

Regenxbio (RGNX) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Regenxbio's Return on Capital Employed [ROCE] came in at -47.21%, up 8.77 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -24.36 percentage points (FY2020 to FY2025).
  • In prior years, Regenxbio's Return on Capital Employed [ROCE] was -55.99% in FY2024 (-9.22 pp), -46.77% in FY2023 (-15.59 pp), -31.18% in FY2022 (-51.67 pp) and 20.50% in FY2021 (+43.36 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -59.93% in Q4 2024 to a high of 19.35% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in four of the last seven quarters, with an average year-over-year change of +6.44 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2022, with a gain of 42.77 percentage points; the weakest was Q3 2023, with a drop of 63.01 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Regenxbio 402.44 Mn -530.65 Mn - -42.72%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.72%
Dec 31, 2025 -43.45%
Sep 30, 2025 -36.15%
Jun 30, 2025 -39.52%
Mar 31, 2025 -42.33%
Dec 31, 2024 -59.93%
Sep 30, 2024 -55.69%
Jun 30, 2024 -49.65%
Mar 31, 2024 -54.10%
Dec 31, 2023 -56.61%
Sep 30, 2023 -49.36%
Jun 30, 2023 -44.89%
Mar 31, 2023 -37.97%
Dec 31, 2022 -36.10%
Sep 30, 2022 13.65%
Jun 30, 2022 13.97%
Mar 31, 2022 13.95%
Dec 31, 2021 19.35%
Sep 30, 2021 -29.13%
Jun 30, 2021 -17.74%
API Access

Regenxbio Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RGNX&period=max&api_key=YOUR_API_KEY